Simvastatin may induce insulin resistance through a novel fatty acid mediated cholesterol independent mechanism
Author:
Publisher
Springer Science and Business Media LLC
Subject
Multidisciplinary
Link
http://www.nature.com/articles/srep13823.pdf
Reference40 articles.
1. Mol, M. J., Erkelens, D. W., Leuven, J. A., Schouten, J. A. & Stalenhoef, A. F. Effects of synvinolin (MK-733) on plasma lipids in familial hypercholesterolaemia. Lancet 2, 936–939 (1986).
2. Tobert, J. A. New developments in lipid-lowering therapy: the role of inhibitors of hydroxymethylglutaryl-coenzyme A reductase. Circulation 76, 534–538 (1987).
3. Simons, L. A., Nestel, P. J., Calvert, G. D. & Jennings, G. L. Effects of MK-733 on plasma lipid and lipoprotein levels in subjects with hypercholesterolaemia. Med J Aust 147, 65–68 (1987).
4. Walker, J. F. & Tobert, J. A. The clinical efficacy and safety of lovastatin and MK-733--an overview. Eur Heart J 8 Suppl E, 93–96 (1987).
5. Olsson, A. G., Molgaard, J. & von Schenk, H. Synvinolin in hypercholesterolaemia. Lancet 2, 390–391 (1986).
Cited by 50 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Genetic association of lipids and lipid-lowering drug targets with the risk of type 1 diabetes and its complications;2024-06-20
2. Exploring peripheral biomarkers of response to simvastatin supplementation in schizophrenia;Schizophrenia Research;2024-04
3. Fluvastatin-induced myofibrillar damage is associated with elevated ROS, and impaired fatty acid oxidation, and is preceded by mitochondrial morphological changes;Scientific Reports;2024-02-09
4. Comparative Efficacy of Rosuvastatin Monotherapy and Rosuvastatin/Ezetimibe Combination Therapy on Insulin Sensitivity and Vascular Inflammatory Response in Patients with Type 2 Diabetes Mellitus;Diabetes & Metabolism Journal;2024-01-31
5. Sesamol combats diabetogenic effects of atorvastatin through GLUT-4 expression and improved pancreatic viability;3 Biotech;2023-10-24
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3